Trial Profile
Single Centre, retrospective, tolerability study of eptifibatide
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Eptifibatide (Primary)
- Indications Stroke
- Focus Adverse reactions
- 12 Aug 2015 New trial record